DataMeds AI Terminates Second Amended LOI With Datavault AI And Partners Due To Market Conditions; No Shares To Be Issued Under LOI, Existing REBOOT And Datavault Agreements Remain In Effect; Co Does Not Owe Any Fees Or Obligation As A Result Of The Termination
DataMeds AI, Inc. ("DataMeds SI," "DataMEDS" or the "Company") (NASDAQ:MEDS), a healthcare company that integrates its health information technology and physical infrastructure with its
DataMeds stopped a deal to buy into another company because market conditions got tough. No money or shares changed hands, and the company owes nothing, so this is more of a pause than a failure.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.